A clinical trial associated with angiotensin II was updated on November 13, 2026. The trial, registered as NCT05834803, is titled "Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients." Its current status is listed as recruiting. The trial phase is listed as not applicable. No results have been posted for this trial as of this update. The listing does not specify outcomes, efficacy, or safety findings at this stage. This update reflects only the trial's registration status and does not indicate conclusions about the study's objectives. Readers should note that recruiting status means the trial is currently seeking or enrolling participants, not that data has been collected or analyzed. No additional details such as enrollment numbers or specific endpoints were included in this update. For further context on angiotensin II as a compound, readers can consult the compound overview.
Trial Update: Angiotensin II Linked Study on Renal Artery Stenosis Recruiting
See the full angiotensin ii overview
Source: https://clinicaltrials.gov/study/NCT05834803